QNTM ▲ +1.6% - Quantum BioPharma Ltd. $QNTM - Rodman & Renshaw Initiates Analyst Coverage on Quantum BioPharma with a BUY Rating and US$8 Price Target Quantum BioPharma gained 1.6% today after Rodman & Renshaw initiated coverage with a BUY rating and an $8 price target on the stock. The new analyst coverage and positive recommendation provided a catalyst for the intraday move upward. 17-SEP-2026 08:00 AM ET